Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$25.26 - $29.6 $159,718 - $187,160
-6,323 Reduced 45.16%
7,679 $215 Million
Q1 2024

May 07, 2024

BUY
$25.89 - $29.73 $19,987 - $22,951
772 Added 5.84%
14,002 $389 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $98,039 - $127,342
3,752 Added 39.59%
13,230 $381 Million
Q3 2023

Nov 17, 2023

BUY
$32.09 - $37.51 $6,642 - $7,764
207 Added 2.23%
9,478 $314 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $99,691 - $115,340
2,760 Added 42.39%
9,271 $340 Million
Q1 2023

May 15, 2023

BUY
$39.39 - $51.28 $3,466 - $4,512
88 Added 1.37%
6,511 $266 Million
Q4 2022

Feb 16, 2023

BUY
$41.75 - $54.5 $268,160 - $350,053
6,423 New
6,423 $329 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Asset Allocation Strategies LLC Portfolio

Follow Asset Allocation Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Allocation Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asset Allocation Strategies LLC with notifications on news.